Cargando…
Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779981/ https://www.ncbi.nlm.nih.gov/pubmed/32757502 http://dx.doi.org/10.3947/ic.2020.52.4.611 |
_version_ | 1783631425341227008 |
---|---|
author | Lee, Hyeyoung Ryu, Ji Hyeong Yun, Sojeong Jang, Joo Hee Choi, Ae-Ran Cho, Sung-Yeon Park, Chulmin Lee, Dong-Gun Oh, Eun-Jee |
author_facet | Lee, Hyeyoung Ryu, Ji Hyeong Yun, Sojeong Jang, Joo Hee Choi, Ae-Ran Cho, Sung-Yeon Park, Chulmin Lee, Dong-Gun Oh, Eun-Jee |
author_sort | Lee, Hyeyoung |
collection | PubMed |
description | The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs. |
format | Online Article Text |
id | pubmed-7779981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS |
record_format | MEDLINE/PubMed |
spelling | pubmed-77799812021-01-05 Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus Lee, Hyeyoung Ryu, Ji Hyeong Yun, Sojeong Jang, Joo Hee Choi, Ae-Ran Cho, Sung-Yeon Park, Chulmin Lee, Dong-Gun Oh, Eun-Jee Infect Chemother Brief Communication The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs. The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2020-12 2020-07-24 /pmc/articles/PMC7779981/ /pubmed/32757502 http://dx.doi.org/10.3947/ic.2020.52.4.611 Text en Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Lee, Hyeyoung Ryu, Ji Hyeong Yun, Sojeong Jang, Joo Hee Choi, Ae-Ran Cho, Sung-Yeon Park, Chulmin Lee, Dong-Gun Oh, Eun-Jee Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title | Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title_full | Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title_fullStr | Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title_full_unstemmed | Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title_short | Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus |
title_sort | evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779981/ https://www.ncbi.nlm.nih.gov/pubmed/32757502 http://dx.doi.org/10.3947/ic.2020.52.4.611 |
work_keys_str_mv | AT leehyeyoung evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT ryujihyeong evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT yunsojeong evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT jangjoohee evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT choiaeran evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT chosungyeon evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT parkchulmin evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT leedonggun evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus AT oheunjee evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus |